169 related articles for article (PubMed ID: 37831150)
1. Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey.
Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; De Oliveira CQ; Verhagen AP
J Neural Transm (Vienna); 2024 Jan; 131(1):43-51. PubMed ID: 37831150
[TBL] [Abstract][Full Text] [Related]
2. The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.
Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; Verhagen AP
Neurol Sci; 2022 Aug; 43(8):4663-4670. PubMed ID: 35593979
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
[TBL] [Abstract][Full Text] [Related]
4. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
[TBL] [Abstract][Full Text] [Related]
5. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
[TBL] [Abstract][Full Text] [Related]
6. Anatomy-guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement?
Kreisler A; Simonin C; Degardin A; Mutez E; Defebvre L
Eur J Neurol; 2020 Nov; 27(11):2142-2146. PubMed ID: 32579789
[TBL] [Abstract][Full Text] [Related]
7. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
Marion MH; Humberstone M; Grunewald R; Wimalaratna S
Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
[TBL] [Abstract][Full Text] [Related]
8. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A and cervical dystonia: a seven-year follow-up.
Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC
Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
11. Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections.
Häkkinen A; Ylinen J; Rinta-Keturi M; Talvitie U; Kautiainen H; Rissanen A
Arch Phys Med Rehabil; 2004 Oct; 85(10):1684-8. PubMed ID: 15468031
[TBL] [Abstract][Full Text] [Related]
12. Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia.
Comella C; Ferreira JJ; Pain E; Azoulai M; Om S
J Neurol; 2021 Mar; 268(3):903-912. PubMed ID: 32939574
[TBL] [Abstract][Full Text] [Related]
13. "Pseudo"-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study.
Hefter H; Rosenthal D; Samadzadeh S
Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888649
[TBL] [Abstract][Full Text] [Related]
14. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
[TBL] [Abstract][Full Text] [Related]
15. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group.
Kessler KR; Skutta M; Benecke R
J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694
[TBL] [Abstract][Full Text] [Related]
17. KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients.
Dec-Ćwiek M; Porębska K; Sawczyńska K; Kubala M; Witkowska M; Zmijewska K; Antczak J; Pera J
Brain Behav; 2022 Apr; 12(4):e2541. PubMed ID: 35238494
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
19. Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia.
Hilker R; Schischniaschvili M; Ghaemi M; Jacobs A; Rudolf J
J Neurol Neurosurg Psychiatry; 2001 Aug; 71(2):193-9. PubMed ID: 11459891
[TBL] [Abstract][Full Text] [Related]
20. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
